Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 629)
Posted On: 01/27/2022 1:22:09 AM
Post# of 153930
Posted By: ohm20
Re: chazzledazzle #116349
Quote:
Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa

association between S gene target failure (SGTF) infection, compared to non-SGTF infection, and severe disease among hospitalised individuals with known outcome, South Africa, 1 October – 30 November 2021

N=317 Severe disease* n/N (%)

SGTF (Omicron) 42/204 (21%)
Non-SGTF (non-Omicron) 45/113 (40%)

* Severe disease defined as a hospitalized patient meeting at least one of the following criteria: admitted to ICU, received oxygen treatment, ventilated, received extracorporeal membrane oxygenation (ECMO), experienced acute respiratory distress syndrome (ARDS) and/or died
















(6)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site